Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Am J Perinatol. 2017 Jun 2;34(14):1389–1395. doi: 10.1055/s-0037-1603655

Fig. 2.

Fig. 2

Graphical representation of the differences in salivary secretory IgA (SsIgA) between colostrum-treated versus control infants. Note that SsIgA increased from baseline day 2 to day 7 in treatment group infants (**p < 0.00001, paired sample t-test). Conversely, SsIgA did not increase over time in the control group infants. SsIgA at the day of life 7 was statistically higher in the colostrum-treated infants (*p < 0.05; independent samples t-test).